(EMAILWIRE.COM, October 17, 2018 ) The Global Ureteral Stents Market, by Product (Double Pigtail Stents, Open-End Stents, Closed-End Stents and Other Stents), by Raw Material (Silicone, Polymer, Metal, and Others), by Application (Ureteroscopy, Lithotripsy, Percutaneous Nephrolithotomy, Kidney Transplantation, Urinary Incontinence, and Others), by End Use (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 492.6 million in 2017 and is projected to exhibit a CAGR of 5.7% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.
Ureteral stents are minimally-invasive method of maintaining ureteral drainage to ensure renal function and treat pain caused due to ureteral obstruction. These stents are an integral part of the treatment of different urological conditions such as malignant obstruction, nephrolithiasis, ureteral stricture, ureteral injury, and healing.
Increasing prevalence of urinary incontinence with age and rising geriatric population are major factors expected to drive the ureteral stents market growth during the forecast period. According to the Global Forum for Incontinence held in 2014, incontinence is a serious medical condition and set of diseases, which affected 4% to 8% of the population or the lives of around 400 million people worldwide over a period of 2007-2010.
Furthermore, lifestyle associated disorders such as obesity and diabetes increase the risk of kidney stone formation, which eventually requires ureteral stents usage during severe condition. According to the Journal of Materials Science report 2008, urolithiasis affects around 12% of the world population at some stage in their lifetime. Although it affects people of all ages, sexes, and races, it is more frequent in men than in women within the age of 2049 years.
However, retaining of ureteral stents for longer duration can cause encrustation, infection, and patient discomfort. Therefore, the use of ureteral stents require timely follow-up in order to avoid increased morbidity, mortality, and healthcare costs.
Request a Sample Copy:http://www.coherentmarketinsights.com/insight/request-sample/2172
Browse 27 Market Data Tables and 33 Figures spread through 175 Pages and in-depth TOC on “Ureteral Stents Market, by Product (Double Pigtail Stents, Open-End Stents, Closed-End Stents, and Other Stents), by Raw Material (Silicone, Polymer, Metal, and Others), by Application (Ureteroscopy, Lithotripsy, Percutaneous Nephrolithotomy, Kidney Transplantation, Urinary Incontinence, and Others), by End Use (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026”
To know the latest trends and insights related to ureteral stents market, click the link below:http://www.coherentmarketinsights.com/market-insight/ureteral-stents-market-2172
Currently, there is no ideal stent available that does not experience failures and complications. Manufacturers are focusing on various advancements in materials, design, and coating of ureteral stents. These advancements aim to address specific causes of stents failure, especially biofilm formation and encrustation. In 2016, BrightWater Medical received FDA approval for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. Combining the most appropriate material, design, and coating would allow the development of an optimal stent.
New designs such as a helically-cut ureteral stent is aimed to stretch and conform the ureter. Drug-eluting stents with an antimicrobial property are designed to reduce bacterial adherence to ureteral stents. Furthermore, bioabsorbable stents are designed to reduce infection and prevent the forgotten stent syndrome. In June 2018, HydrUStent, a startup based at the University of Minho in Portugal, announced its research on developing a ureteral stent made from a patented material that is homogeneous, antibacterial, and biodegradable.
Key Takeaways of the Ureteral Stents Market:
The global ureteral stents market is expected to expand at a CAGR of 5.7% during the forecast period (20182026), owing to increasing cases of kidney stones that occur due to rising obesity and diabetes prevalence. According to the National Kidney Foundation 2017 report, it is estimated that one in ten people will have a kidney stone at some point of time.
Among product, the double pigtail stents segment is expected to generate significant revenue in 2018, owing to increasing adoption of these products coupled with high efficiency.
Among end use, the hospital segment is expected witness growth at high rate, owing to increasing number of kidney and ureter procedures being performed.
Major players operating in the global ureteral stents market include, Applied Medical, Allium Medical, Bard Medical, B.Braun, Boston Scientific, Cook Medical, Coloplast, Conmed Corporation, Optimed, Olympus America, Pnn Medical A/S, Taewoong Medical, Teleflex, Uromed, and Urotech.
Pareesh Phulkar
8087996871
pareesh@coherentmarketinsights.com
Source: EmailWire.Com 
http://emailwire.com/release/941006-Ureteral-Stents-Market-to-Surpass-US-793-Million-by-2026.html
